Data reported today include safety, biopsy and arrhythmia results from three patients who received TN-401 at a dose of 3E13 vg/kg. Patient follow-up at the time of data cut off ranged from 20-40 weeks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback